SPINK2 knockdown reduces proliferation and promotes cell death in MLL–MLLT3-rearranged THP-1 cells
- 3 November 2026
- journal article
- research article
- Published by Springer Nature in Histochemistry and Cell Biology
- Vol. 164 (1) , 101
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- SPINK2 in hematopoiesis and cancer: Biology and clinical implicationsCell Death Discovery, 2026
- SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemiaCell Death Discovery, 2026
- Temporary serine protease inhibition and the role of SPINK2 in human bone marrowiScience, 2023
- Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELNBlood, 2022
- SLC7A11/GPX4 Inactivation‐Mediated Ferroptosis Contributes to the Pathogenesis of Triptolide‐Induced CardiotoxicityOxidative Medicine and Cellular Longevity, 2022
- Prior cytopenia predicts worse clinical outcome in acute myeloid leukemiaLeukemia Research, 2015
- Spink2 Modulates Apoptotic Susceptibility and Is a Candidate Gene in the Rgcs1 QTL That Affects Retinal Ganglion Cell Death after Optic Nerve DamagePLOS ONE, 2014
- Identification of trypsin‐inhibitory site and structure determination of human SPINK2 serine proteinase inhibitorProteins: Structure, Function, and Bioinformatics, 2009
- MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte–macrophage maturation in AML-M5 THP-1 cellsOncogene, 2003
- Consistent detection of CALM‐AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcriptsBritish Journal of Haematology, 1999